Literature DB >> 16735346

Inhaled insulin: concerns remain.

Niamh M Martin, Karim Meeran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16735346      PMCID： PMC1471927          DOI： 10.1136/bmj.332.7552.1273-e

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Inhaled insulin.

Authors:  Emma Morton-Eggleston; Eugene J Barrett
Journal:  BMJ       Date:  2006-05-06

2.  The clinical relevance of inhaled insulin in the diabetic lung.

Authors:  John Teeter; Reinhard Becker
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

3.  Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Teresa Quattrin; André Bélanger; Nancy J V Bohannon; Sherwyn L Schwartz
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

4.  Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

Authors:  Jay S Skyler; Ruth S Weinstock; Philip Raskin; Jean-François Yale; Eugene Barrett; John E Gerich; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

Review 5.  The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin.

Authors:  Connie C W Hsia; Philip Raskin
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.